IRIS publication 111460505
Sustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR-ABL chronic myeloid leukemia.
RIS format for Endnote and similar
TY - JOUR - Langabeer SE, Crampe M, Haslam K, Kelly J, Cahill MR - 2010 - July - Leukemia Research - Sustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR-ABL chronic myeloid leukemia. - Validated - () - 34 - 7 - 1 - 7 - 10.1016/j.leukres.2010.01.025 DA - 2010/07 ER -
BIBTeX format for JabRef and similar
@article{V111460505, = {Langabeer SE, Crampe M and Haslam K, Kelly J and Cahill MR }, = {2010}, = {July}, = {Leukemia Research}, = {Sustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR-ABL chronic myeloid leukemia.}, = {Validated}, = {()}, = {34}, = {7}, pages = {1--7}, = {10.1016/j.leukres.2010.01.025}, source = {IRIS} }
Data as stored in IRIS
AUTHORS | Langabeer SE, Crampe M, Haslam K, Kelly J, Cahill MR | ||
YEAR | 2010 | ||
MONTH | July | ||
JOURNAL_CODE | Leukemia Research | ||
TITLE | Sustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR-ABL chronic myeloid leukemia. | ||
STATUS | Validated | ||
TIMES_CITED | () | ||
SEARCH_KEYWORD | |||
VOLUME | 34 | ||
ISSUE | 7 | ||
START_PAGE | 1 | ||
END_PAGE | 7 | ||
ABSTRACT | |||
PUBLISHER_LOCATION | |||
ISBN_ISSN | |||
EDITION | |||
URL | |||
DOI_LINK | 10.1016/j.leukres.2010.01.025 | ||
FUNDING_BODY | |||
GRANT_DETAILS |